Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Cannabis and Cannabinoid Research, Liver Disease Diagnosis and Treatment, and Cardiac Health and Mental Health.
Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study
Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration
Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia
Independent and joint associations of cardiorespiratory fitness and BMI with dementia risk: the Cooper Center Longitudinal Study
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study
Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium
Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Study
Book-Oriented Environment in Childhood and Current Cognitive Performance among Old-Aged Europeans
Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study
The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts
Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
Associations between social relationship measures, serum brain‐derived neurotrophic factor, and risk of stroke and dementia
Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)
Association of Alzheimer's disease GWAS loci with MRI markers of brain aging
Plasma amyloid‐β and risk of Alzheimer's disease in the Framingham Heart Study
Genome-Wide Meta-Analysis of Homocysteine and Methionine Metabolism Identifies Five One Carbon Metabolism Loci and a Novel Association of ALDH1L1 with Ischemic Stroke
Cognitive Performance after Stroke – The Framingham Heart Study
Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia
Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study